Loading company…
Barcelona-based biotech company that uses AI to repurpose existing drugs for diseases of the central nervous system.
Founded in 2009 by Raúl Insa (President/CEO) and based in Barcelona, Spain, SOM Innovation Biotech, SA develops and repurposes drugs for diseases of the central nervous system. The company uses artificial intelligence to find new indications for existing drugs, including TTR Amyloidosis, Huntington's disease and Niemann-Pick disease. In December 2023, it raised USD 17 million in Series B funding from EIB and the Prevail Partner Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in